NEW YORK (WABC) -- Britain has granted a conditional authorization to Merck's coronavirus antiviral, the first pill shown to successfully treat COVID-19. It is the first country to OK the treatment, ...

The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...

Paxlovid, an FDA-approved oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it as soon as possible ...

CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...

NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

Pfizer said Tuesday morning that final trial studies still show its experimental COVID-19 pill significantly reduced the risk of hospitalization or death linked to the virus by 89%. The company also ...

Add Yahoo as a preferred source to see more of our stories on Google. By now, most people have reached a resigned acceptance when it comes to COVID-19. We accept that we’re probably going to get ...

But what if you could avoid getting COVID-19 altogether? That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific conference in San ...